JFNSX Mutual Fund (Janus Henderson Global Life Sciences Fund Class S) is managed by Janus Henderson Investors. JFNSX expense ratio is 1.19%, holding 109 positions across sectors including Health Care, Unknown, Other. Inception date: 2009-07-06.

JFNSX performance shows a YTD return of 8.33%. The 1-year return is 38.94% and the 5-year return is 9.04%. JFNSX dividend yield stands at 4.23%, paid annually.

JFNSX top holdings include Eli Lilly And Company (9.7%), JOHNSON AND JOHNSON (5.6%), Astrazeneca Plc Adr (4.3%), Unitedhealth Group, Inc. (3.4%), Abbvie Inc Health Care (3.4%). View all JFNSX holdings, sector breakdown, or dividend history.

JFNSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JFNSX alternatives are available via the screener, along with tax-loss harvesting opportunities.